30 studies found for:    alzheimer | glaxosmithkline
Show Display Options
Rank Status Study
1 Completed Modulation of Abeta Levels by GSK933776 in Alzheimer's Disease Patient
Condition: Alzheimer's Disease
Intervention: Biological: GSK933776
2 Completed Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy For Subjects With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Rosiglitazone Extended Release 2mg;   Drug: Rosiglitazone Extended Release 8mg;   Other: Placebo;   Other: Donepezil
3 Completed A Phase 2a Study to Evaluate the Effect of Rilapladib (SB-659032) in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: 250mg rilapladib;   Drug: placebo
4 Completed Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: Rosiglitazone
5 Completed Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Rosiglitazone Extended Release 2mg;   Drug: Rosiglitazone Extended Release 8mg;   Other: Placebo
6 Completed A Clinical Study to Assess Single and Repeat Doses of a New Medication (GSK933776) in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: GSK933776;   Drug: Placebo to match GSK933776
7 Completed Bridging Study With GSK239512 In Patients With Mild To Moderate Alzheimer's Disease
Conditions: Alzheimer's Disease;   Mild to Moderate Alzheimers Disease
Interventions: Drug: GSK239512;   Drug: Placebo
8 Completed A Study of SB-742457, Added to Donepezil for the Treatment of Mild-to-moderate Alzheimer's Disease
Conditions: Mild-to-moderate Alzheimer's Disease;   Alzheimer's Disease
Interventions: Drug: SB-742457 15mg;   Drug: SB-742457 35mg;   Drug: Placebo;   Drug: donepezil 5-10mg
9 Completed SB-742457 And Donepezil In Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: SB-742457;   Drug: donepezil
10 Completed Study of SB-742457 or Donepezil Versus Placebo in Subjects With Mild-to-moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: SB-742457;   Drug: Donepezil;   Drug: Placebo
11 Completed A Dose Ranging Study To Investigate The Efficacy And Safety Of SB-742457 In Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: SB-742457
12 Terminated Effects Of Rosiglitazone (Extended Release Tablets) On Cerebral Glucose Utilisation And Cognition Alzheimers Disease
Condition: Alzheimer's Disease
Interventions: Drug: Rosiglitazone XR (extended release) oral tablets;   Drug: Placebo
13 Completed Mild Alzheimer''s Disease to Assess the of Extended Release Formulation of Rosiglitazone (RSG XR)
Condition: Alzheimer's Disease
Intervention: Drug: Rosiglitazone (Extended Release)
14 Completed Study to Evaluate the Efficacy and Safety of GSK239512 in Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: GSK239512;   Drug: Placebo
15 Completed Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Rosiglitazone;   Other: Placebo
16 Completed Open-Label Extension Assessing Long-Term Safety Of Rosiglitazone In Subjects With Mild To Moderate Alzheimer's Disease
Condition: Alzheimer's Disease
Intervention: Drug: rosiglitazone
17 Terminated Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers
Condition: Alzheimer's Disease
Intervention: Drug: Rosiglitazone XR
18 Terminated Open-Label Extension Study Of Rosiglitazone XR As Adjunctive Therapy In Subjects With Mild-to-Moderate Alzheimers
Condition: Alzheimer's Disease
Intervention: Drug: Rosiglitazone XR
19 Terminated GSK2647544 RD, DDI in Healthy Young and Elderly Volunteers
Condition: Alzheimer's Disease
Interventions: Drug: GSK2647544;   Drug: drug-drug interaction
20 Not yet recruiting Study to Determine the Effect of Itraconazole on the Pharmacokinetics of Rilapladib (SB659032) in Healthy Volunteers
Condition: Alzheimer's Disease
Interventions: Drug: Rilapladib 25 mg;   Drug: Rilapladib 250 mg;   Drug: Itraconazole

Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results
Indicates status has not been verified in more than two years